首页 > 最新文献

World Journal of Acupuncture-Moxibustion最新文献

英文 中文
Global acupuncture randomized controlled trials: Evaluating status, guideline impact, and future research trends 全球针灸随机对照试验:评估现状、指南影响和未来研究趋势
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.09.004
Gao-feng LIU (刘高峰) , Xiao-li HUANG (黄小力) , Wei-xing ZHONG (钟伟兴) , Yin XIE (解寅) , Si-yuan XIE (谢思远) , Yuan-xun LIN (林源洵) , Yun-ao-long ZHANG (张沄奡龙) , Hong-wen LIU (刘洪文) , Qing-guang QIN (秦庆广) , Yi-kai LI (李义凯)

Objectives

This study aims to evaluate the current state of acupuncture randomized controlled trials (RCTs), their impact on guidelines, and future development trends, providing a reference for future research directions.

Methods

Search for acupuncture-related RCT articles in the Web of Science Core Collection and confirm their guideline inclusion on Google Scholar. Analyze study characteristics to predict future research directions.

Results

The analysis covered 1422 articles, reflecting a substantial rise in publications from 77 articles between 1993 and 2002 to 960 articles between 2013 and 2022. The Western Pacific region led in publication numbers with 622 articles (43.7 %), followed by Europe (466 articles; 32.8 %), Americas (250 articles; 17.6 %), Eastern Mediterranean (62 articles; 4.4 %), and Southeast Asia (22 articles; 1.5 %), with Africa showing a research void. Regrettably, only 29.6 % (421 articles) were incorporated into guidelines. The low rate of inclusion of research results in guidelines and the uneven distribution of research fields are particularly prominent. From 1993 to 2002, there were 77 articles, among which 51 (66.2 %) were included in the guidelines; from 2003 to 2012, there were 385 articles, with 202 (52.5 %) included; from 2013 to 2022, there were 960 articles, and only 168 (17.5 %) were included, showing a decreasing trend in the inclusion rate year by year. Regarding geographical distribution, 1167 articles were from the Eastern Hemisphere, with 326 (27.9 %) included; 255 were from the Western Hemisphere, and 95 (37.3 %) were included. Regionally, 179 articles (42.5 %) from Europe were included, 140 (33.3 %) from the Western Pacific, 95 (22.6 %) from the Americas, 6 (1.4 %) from the Eastern Mediterranean, and 1 (0.2 %) from Southeast Asia. China, the United States, and Germany were the top publishing countries, with consistent growth in countries like China, South Korea, Spain, Brazil, Turkey, and Iran. Noteworthy researchers such as Cesar Fernandez-de-las-Penas, Zhi-shun LIU, Jing-wen YANG, Cun-zhi LIU, Li-xing LAO, Stefan N Willich, and Benno Brinkhaus have collaborated on research in areas such as pain management, cognitive impairments, insomnia, digestive system diseases, and urinary system diseases. There has been a particular increase in research focus on neck pain and myofascial trigger points.

Conclusion

Despite the growth in acupuncture RCTs, their impact on revising medical guidelines remains disproportionate. The skewed geographic distribution underscores the urgent need for more comprehensive, regionally-targeted trials to foster globally applicable outcomes.
目的评价针刺随机对照试验(RCTs)的现状、对指南的影响及未来发展趋势,为今后的研究方向提供参考。方法在Web of Science核心馆藏中检索与针灸相关的随机对照试验文献,确认纳入b谷歌Scholar指南。分析研究特点,预测未来研究方向。该分析涵盖了1422篇文章,反映了出版物从1993年至2002年的77篇文章大幅增加到2013年至2022年的960篇文章。西太平洋地区以622篇(43.7%)的论文发表数量领先,其次是欧洲(466篇,32.8%)、美洲(250篇,17.6%)、东地中海(62篇,4.4%)和东南亚(22篇,1.5%),非洲显示出研究空白。遗憾的是,只有29.6%(421篇)文章被纳入指南。研究成果纳入指南率低和研究领域分布不均的问题尤为突出。1993 - 2002年共有77条,其中51条(66.2%)被纳入指南;2003 - 2012年共收录文献385篇,其中202篇(52.5%);2013 - 2022年共960篇文章,其中只有168篇(17.5%)被收录,收录率呈逐年下降趋势。地理分布方面,来自东半球的文献1167篇,其中326篇(27.9%);255例来自西半球,其中95例(37.3%)。从地区上看,179篇(42.5%)来自欧洲,140篇(33.3%)来自西太平洋,95篇(22.6%)来自美洲,6篇(1.4%)来自东地中海,1篇(0.2%)来自东南亚。中国、美国和德国是发行量最大的国家,中国、韩国、西班牙、巴西、土耳其和伊朗等国家的发行量也在持续增长。Cesar Fernandez-de-las-Penas、LIU zhishun、YANG Jing-wen、LIU存之、LAO Li-xing、Stefan N Willich、Benno Brinkhaus等知名研究人员在疼痛管理、认知障碍、失眠、消化系统疾病和泌尿系统疾病等领域进行了合作研究。特别是对颈部疼痛和肌筋膜触发点的研究增加了。结论尽管针灸随机对照试验的数量有所增加,但其对修订医疗指南的影响仍然不成比例。这种倾斜的地理分布突出表明,迫切需要开展更全面、更有针对性的试验,以促进全球适用的结果。
{"title":"Global acupuncture randomized controlled trials: Evaluating status, guideline impact, and future research trends","authors":"Gao-feng LIU (刘高峰) ,&nbsp;Xiao-li HUANG (黄小力) ,&nbsp;Wei-xing ZHONG (钟伟兴) ,&nbsp;Yin XIE (解寅) ,&nbsp;Si-yuan XIE (谢思远) ,&nbsp;Yuan-xun LIN (林源洵) ,&nbsp;Yun-ao-long ZHANG (张沄奡龙) ,&nbsp;Hong-wen LIU (刘洪文) ,&nbsp;Qing-guang QIN (秦庆广) ,&nbsp;Yi-kai LI (李义凯)","doi":"10.1016/j.wjam.2025.09.004","DOIUrl":"10.1016/j.wjam.2025.09.004","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aims to evaluate the current state of acupuncture randomized controlled trials (RCTs), their impact on guidelines, and future development trends, providing a reference for future research directions.</div></div><div><h3>Methods</h3><div>Search for acupuncture-related RCT articles in the Web of Science Core Collection and confirm their guideline inclusion on Google Scholar. Analyze study characteristics to predict future research directions.</div></div><div><h3>Results</h3><div>The analysis covered 1422 articles, reflecting a substantial rise in publications from 77 articles between 1993 and 2002 to 960 articles between 2013 and 2022. The Western Pacific region led in publication numbers with 622 articles (43.7 %), followed by Europe (466 articles; 32.8 %), Americas (250 articles; 17.6 %), Eastern Mediterranean (62 articles; 4.4 %), and Southeast Asia (22 articles; 1.5 %), with Africa showing a research void. Regrettably, only 29.6 % (421 articles) were incorporated into guidelines. The low rate of inclusion of research results in guidelines and the uneven distribution of research fields are particularly prominent. From 1993 to 2002, there were 77 articles, among which 51 (66.2 %) were included in the guidelines; from 2003 to 2012, there were 385 articles, with 202 (52.5 %) included; from 2013 to 2022, there were 960 articles, and only 168 (17.5 %) were included, showing a decreasing trend in the inclusion rate year by year. Regarding geographical distribution, 1167 articles were from the Eastern Hemisphere, with 326 (27.9 %) included; 255 were from the Western Hemisphere, and 95 (37.3 %) were included. Regionally, 179 articles (42.5 %) from Europe were included, 140 (33.3 %) from the Western Pacific, 95 (22.6 %) from the Americas, 6 (1.4 %) from the Eastern Mediterranean, and 1 (0.2 %) from Southeast Asia. China, the United States, and Germany were the top publishing countries, with consistent growth in countries like China, South Korea, Spain, Brazil, Turkey, and Iran. Noteworthy researchers such as Cesar Fernandez-de-las-Penas, Zhi-shun LIU, Jing-wen YANG, Cun-zhi LIU, Li-xing LAO, Stefan N Willich, and Benno Brinkhaus have collaborated on research in areas such as pain management, cognitive impairments, insomnia, digestive system diseases, and urinary system diseases. There has been a particular increase in research focus on neck pain and myofascial trigger points.</div></div><div><h3>Conclusion</h3><div>Despite the growth in acupuncture RCTs, their impact on revising medical guidelines remains disproportionate. The skewed geographic distribution underscores the urgent need for more comprehensive, regionally-targeted trials to foster globally applicable outcomes.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 331-340"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moxibustion modulates gut microbiota and improves bone marrow hematopoiesis in mice with myelosuppression-induced aplastic anemia 艾灸调节骨髓抑制性再生障碍性贫血小鼠的肠道微生物群并改善骨髓造血功能
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.09.003
Wen-qing HU (胡文清) , Jian-fei SHI (石健菲) , Yuan LU (陆嫄) , Huan-gan WU (吴焕淦) , Guo-na LI (李国娜) , Xiao-ling YIN (殷晓聆) , Dan-li JIAO (焦丹丽) , Jing LI (李璟) , Ling-xiang WU (吴凌翔) , Chen ZHAO (赵琛)

Objective

To observe the effects of moxibustion on the hematopoietic function in mice with aplastic anemia (AA) induced by bone marrow (BM) suppression, and to investigate the intervention effects of moxibustion on AA from the perspective of intestinal bacteria.

Methods

A total of 24 C57BL/6 J male mice were randomly and evenly divided into control, model and moxibustion groups. The myelosuppression-induced AA model was established by cyclophosphamide (CTX) and cyclosporine (Cs) intraperitoneal injection. Mice in the moxibustion group were intervened in mild moxibustion at unilateral “Zusanli(ST36)” acupoint for 15 min per day, and the sides were switched the next day. The intervention of mild moxibustion lasted 60 days consecutively. The red blood cell (RBC), white blood cell (WBC), platelet (PLT) counts and haemoglobin (Hb) concentration levels of mice in each group were detected by peripheral blood cells count staining, and the BM hematopoietic cells and hematopoietic structures were observed by BM smear Wright-Giemsa staining and HE staining. 16SrDNA sequencing was used to analyze the gut bacterial species abundance and diversity in mice from each group.

Results

After all the intervention, compared to the control group, the model group had lower levels of RBC, WBC, PLT counts and Hb concentration in peripheral blood (P < 0.05) and fewer hematopoietic cells and hematopoietic structures; compared to the model group, moxibustion group had higher levels of RBC, WBC, PLT counts and Hb concentration in peripheral blood (P < 0.05), and more BM hematopoietic cells and hematopoietic structures. Gut flora showed that moxibustion increased the species richness and diversity of intestinal bacteria in mice; compared with the control group, the relative abundance of Faecalibaculum and Anaeroplasmataceae in the model group was higher (P < 0.05); whereas, the relative abundance of Faecalibaculum and Anaeroplasmataceae in the moxibustion group was lower (P < 0.05) when compared with the model group. In addition, Faecalibaculum was significantly correlated with RBC, WBC, PLT count and Hb concentration (P < 0.05).

Conclusion

Moxibustion can improved BM histology, restored hematopoietic cells function, and increased peripheral blood cells count and Hb concentration in AA mice. The mechanism may be related to the fact that moxibustion regulates the abundance of specific intestinal bacteria to maintain the stability of the flora structure.
目的观察艾灸对骨髓抑制所致再生障碍性贫血(AA)小鼠造血功能的影响,并从肠道菌群角度探讨艾灸对AA的干预作用。方法将24只C57BL/ 6j雄性小鼠随机平均分为对照组、模型组和艾灸组。采用环磷酰胺(CTX)和环孢素(Cs)腹腔注射建立小鼠骨髓抑制AA模型。艾灸组小鼠在单侧“足三里(ST36)”穴轻度灸15 min,每天干预,次日换侧。轻度艾灸干预连续60 d。外周血细胞计数染色检测各组小鼠红细胞(RBC)、白细胞(WBC)、血小板(PLT)计数和血红蛋白(Hb)浓度水平,BM涂片Wright-Giemsa染色和HE染色观察BM造血细胞和造血结构。采用16SrDNA测序分析各组小鼠肠道细菌种类丰度和多样性。结果干预后,模型组大鼠外周血RBC、WBC、PLT计数及Hb浓度均低于对照组(P < 0.05),造血细胞及造血结构减少;与模型组比较,艾灸组外周血RBC、WBC、PLT计数及Hb浓度升高(P < 0.05), BM造血细胞增多,造血结构增多。肠道菌群显示,艾灸可增加小鼠肠道细菌的种类丰富度和多样性;与对照组相比,模型组Faecalibaculum和Anaeroplasmataceae的相对丰度较高(P < 0.05);而艾灸组Faecalibaculum和Anaeroplasmataceae的相对丰度较模型组降低(P < 0.05)。粪足量与RBC、WBC、PLT计数及Hb浓度显著相关(P < 0.05)。结论艾灸能改善AA小鼠脑梗死组织学,恢复造血细胞功能,增加外周血细胞计数和Hb浓度。其机制可能与艾灸调节肠道特定菌群的丰度,维持菌群结构的稳定有关。
{"title":"Moxibustion modulates gut microbiota and improves bone marrow hematopoiesis in mice with myelosuppression-induced aplastic anemia","authors":"Wen-qing HU (胡文清) ,&nbsp;Jian-fei SHI (石健菲) ,&nbsp;Yuan LU (陆嫄) ,&nbsp;Huan-gan WU (吴焕淦) ,&nbsp;Guo-na LI (李国娜) ,&nbsp;Xiao-ling YIN (殷晓聆) ,&nbsp;Dan-li JIAO (焦丹丽) ,&nbsp;Jing LI (李璟) ,&nbsp;Ling-xiang WU (吴凌翔) ,&nbsp;Chen ZHAO (赵琛)","doi":"10.1016/j.wjam.2025.09.003","DOIUrl":"10.1016/j.wjam.2025.09.003","url":null,"abstract":"<div><h3>Objective</h3><div>To observe the effects of moxibustion on the hematopoietic function in mice with aplastic anemia (AA) induced by bone marrow (BM) suppression, and to investigate the intervention effects of moxibustion on AA from the perspective of intestinal bacteria.</div></div><div><h3>Methods</h3><div>A total of 24 C57BL/6 J male mice were randomly and evenly divided into control, model and moxibustion groups. The myelosuppression-induced AA model was established by cyclophosphamide (CTX) and cyclosporine (Cs) intraperitoneal injection. Mice in the moxibustion group were intervened in mild moxibustion at unilateral “Zusanli(ST36)” acupoint for 15 min per day, and the sides were switched the next day. The intervention of mild moxibustion lasted 60 days consecutively. The red blood cell (RBC), white blood cell (WBC), platelet (PLT) counts and haemoglobin (Hb) concentration levels of mice in each group were detected by peripheral blood cells count staining, and the BM hematopoietic cells and hematopoietic structures were observed by BM smear Wright-Giemsa staining and HE staining. 16SrDNA sequencing was used to analyze the gut bacterial species abundance and diversity in mice from each group.</div></div><div><h3>Results</h3><div>After all the intervention, compared to the control group, the model group had lower levels of RBC, WBC, PLT counts and Hb concentration in peripheral blood (<em>P</em> &lt; 0.05) and fewer hematopoietic cells and hematopoietic structures; compared to the model group, moxibustion group had higher levels of RBC, WBC, PLT counts and Hb concentration in peripheral blood (<em>P</em> &lt; 0.05), and more BM hematopoietic cells and hematopoietic structures. Gut flora showed that moxibustion increased the species richness and diversity of intestinal bacteria in mice; compared with the control group, the relative abundance of <em>Faecalibaculum</em> and <em>Anaeroplasmataceae</em> in the model group was higher (<em>P</em> &lt; 0.05); whereas, the relative abundance of <em>Faecalibaculum</em> and <em>Anaeroplasmataceae</em> in the moxibustion group was lower (<em>P</em> &lt; 0.05) when compared with the model group. In addition, <em>Faecalibaculum</em> was significantly correlated with RBC, WBC, PLT count and Hb concentration (<em>P</em> &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>Moxibustion can improved BM histology, restored hematopoietic cells function, and increased peripheral blood cells count and Hb concentration in AA mice. The mechanism may be related to the fact that moxibustion regulates the abundance of specific intestinal bacteria to maintain the stability of the flora structure.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 357-366"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
China Association of Acupuncture and Moxibustion leading the development of acupuncture-moxibustion discipline: Achievement and practice 中国针灸学会引领针灸学科发展:成就与实践
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.08.003
Yin-long LI (李印泷), Shu-dong LI (李述东), Yuan WU (吴远), Wen-jun YI (易文军), Qiu-fang ZUO (左秋芳), Xiao-chun YU (喻晓春)
China Association of Acupuncture and Moxibustion (CAAM) is the largest acupuncture-moxibustion individual member science and technology group in the world, and has become an important academic organization leading the development of international acupuncture-moxibustion discipline over the past 40 years. This paper systematically reviews the work of CAAM in international communication, policy making, basic research, scientific knowledge popularization and integrated development of industry, education and research. (1) Enhancing the world recognition of acupuncture and moxibustion by means of innovation. (2) Building a highland for the domestic development of acupuncture and moxibustion with comprehensive strategies. (3) Consolidating the foundation for the development of acupuncture-moxibustion discipline. (4) Driving scientific knowledge popularization in a variety of forms and contents. (5) Coordinating resources to promote integrated development of industry, education and research. Guided by inheriting the essence and maintaining the right while innovating, CAAM has played an important role in promoting the modernization and internationalization of acupuncture-moxibustion discipline, and contributed to the construction of Healthy China initiative with our wisdom. Focusing on domestic and international perspectives, CAAM strives to promote the development of acupuncture-moxibustion discipline and industry, and contribute greatly to health for all with acupuncture and moxibustion. CAAM will continue to deepen international cooperation, strengthen talent cultivation, promote the commercialization of scientific and research findings, advance the standardization of acupuncture-moxibustion equipment and techniques and build a unified standard system of acupuncture and moxibustion worldwide.
中国针灸学会是世界上最大的针灸个人会员科技团体,经过40多年的发展,已成为引领国际针灸学科发展的重要学术组织。本文系统回顾了中国农业科学院在国际交流、政策制定、基础研究、科学知识普及和产学研融合发展等方面的工作。(1)通过创新提高世界对针灸的认知度。(2)以综合战略打造国内针灸发展高地。(3)夯实针灸学科发展基础。(4)以多种形式和内容推动科学知识普及。(五)统筹资源,促进产学研融合发展。中国针灸学会秉承“继承精华、保持正确、创新”的指导方针,在推动针灸学科现代化、国际化进程中发挥了重要作用,用自己的智慧为健康中国建设做出了贡献。中国针灸学会立足国内,面向国际,致力于推动针灸学科和针灸行业的发展,为促进针灸健康做出积极贡献。中国针灸学会将继续深化国际合作,加强人才培养,促进科研成果的商业化,推进针灸设备和技术的标准化,建立世界范围内统一的针灸标准体系。
{"title":"China Association of Acupuncture and Moxibustion leading the development of acupuncture-moxibustion discipline: Achievement and practice","authors":"Yin-long LI (李印泷),&nbsp;Shu-dong LI (李述东),&nbsp;Yuan WU (吴远),&nbsp;Wen-jun YI (易文军),&nbsp;Qiu-fang ZUO (左秋芳),&nbsp;Xiao-chun YU (喻晓春)","doi":"10.1016/j.wjam.2025.08.003","DOIUrl":"10.1016/j.wjam.2025.08.003","url":null,"abstract":"<div><div>China Association of Acupuncture and Moxibustion (CAAM) is the largest acupuncture-moxibustion individual member science and technology group in the world, and has become an important academic organization leading the development of international acupuncture-moxibustion discipline over the past 40 years. This paper systematically reviews the work of CAAM in international communication, policy making, basic research, scientific knowledge popularization and integrated development of industry, education and research. (1) Enhancing the world recognition of acupuncture and moxibustion by means of innovation. (2) Building a highland for the domestic development of acupuncture and moxibustion with comprehensive strategies. (3) Consolidating the foundation for the development of acupuncture-moxibustion discipline. (4) Driving scientific knowledge popularization in a variety of forms and contents. (5) Coordinating resources to promote integrated development of industry, education and research. Guided by inheriting the essence and maintaining the right while innovating, CAAM has played an important role in promoting the modernization and internationalization of acupuncture-moxibustion discipline, and contributed to the construction of Healthy China initiative with our wisdom. Focusing on domestic and international perspectives, CAAM strives to promote the development of acupuncture-moxibustion discipline and industry, and contribute greatly to health for all with acupuncture and moxibustion. CAAM will continue to deepen international cooperation, strengthen talent cultivation, promote the commercialization of scientific and research findings, advance the standardization of acupuncture-moxibustion equipment and techniques and build a unified standard system of acupuncture and moxibustion worldwide.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 393-397"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neural anatomical connections between "Shenshu(BL 23)" "Guanyuan(CV 4)" and the ovary in rats 大鼠“肾俞”、“官源”与卵巢的神经解剖学联系
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.09.008
Huan-fang XU (许焕芳) , Peng-fei DU (杜鹏飞) , Dong-sheng XU (徐东升), Jing-jing Cui (崔晶晶), Yi-gong FANG (房繄恭), Jia WANG (王佳), Li YANG (杨莉)

Objective

To investigate the distribution characteristics of sensory, sympathetic, and motor neurons associated with the "Shenshu (BL 23)" and "Guanyuan (CV 4)" acupoints and the ovary, and to elucidate the neural anatomical connections between these acupoints and the ovary.

Methods

In this study, dual fluorescent neural tracing was utilized, with twelve female Sprague-Dawley rats being randomly allocated into two groups (n = 6 per group) for the purpose of administering tracer injections at distinct anatomical sites: the "BL 23"-ovary group received injections of Alexa Fluor 488-conjugated cholera toxin subunit B (AF488-CTB) at the left "BL 23" and Fluoro-Gold (FG) in the left ovary; the "CV 4"-ovary group received AF488-CTB at “CV 4” and FG in the left ovary. Three days post-injection, the distribution of AF488-CTB and FG-labeled neural components was observed in the dorsal root ganglia (DRGs), sympathetic chain, and spinal cord tissues.

Results

① Sensory neurons labeled with AF488-CTB associated with "BL 23" were primarily distributed in the thoracic (T) 10 to lumbar (L) 2 DRGs, concentrated in T12-T13; postganglionic sympathetic neurons were mainly located in the thoracolumbar sympathetic chain; motor neurons were predominantly found in the anterior horn of the T11-L1 spinal cord segments. ② Sensory neurons labeled with AF488-CTB associated with "CV 4" were primarily located in T10-L3 DRGs, concentrated in T13-L2 DRGs; postganglionic sympathetic neurons were mainly distributed in the lumbar sympathetic chain; motor neurons were primarily found in the anterior horn of T11-L2 spinal cord segments. ③ FG-labeled sensory neurons associated with the ovary were mainly distributed in the T9-L3 DRGs, concentrated in the T12-L2 DRGs; postganglionic sympathetic neurons were primarily located in the lumbar sympathetic chain. ④ Double-labeled (AF488-CTB and FG) sensory neurons associated with the "BL 23" and ovary were mainly distributed in the T12-T13 DRGs, with double-labeled postganglionic sympathetic neurons primarily in the lumbar sympathetic chain; double-labeled sensory neurons associated with the "CV 4" and ovary were mainly distributed in the T13-L1 DRGs, with double-labeled postganglionic sympathetic neurons primarily in the lumbar sympathetic chain. No double-labeled motor neurons were observed for either acupoint with the ovary.

Conclusion

"BL 23" and "CV 4" and the ovary in rats exhibit segmental connections in sensory and sympathetic innervation, which may serve as the neural anatomical pathway and basis for acupuncture at these acupoints to regulate ovarian function.
目的探讨肾俞穴和观园穴与卵巢相关的感觉、交感和运动神经元的分布特征,并阐明这些穴位与卵巢的神经解剖学联系。方法采用双荧光神经示踪方法,将12只雌性sd大鼠随机分为两组(每组6只),分别在不同解剖部位注射示踪剂:“bl23”卵巢组在左侧“bl23”和左侧卵巢分别注射Alexa氟488结合霍乱毒素亚基B (AF488-CTB)和氟金(FG);“cv4”-卵巢组在“cv4”处注射AF488-CTB,左卵巢注射FG。注射后3 d,观察AF488-CTB和fg标记的神经成分在大鼠背根神经节、交感神经链和脊髓组织中的分布。结果①与“BL 23”相关的AF488-CTB标记的感觉神经元主要分布在胸(T) 10 ~腰(L) 2 DRGs,集中在T12-T13;节后交感神经元主要位于胸腰椎交感神经链;运动神经元主要分布于脊髓T11-L1节段的前角。②与“cv4”相关的AF488-CTB标记的感觉神经元主要位于T10-L3 DRGs,集中在T13-L2 DRGs;节后交感神经元主要分布于腰交感神经链;运动神经元主要分布于脊髓T11-L2节段的前角。③与卵巢相关的fg标记感觉神经元主要分布在T9-L3 DRGs,集中在T12-L2 DRGs;节后交感神经元主要位于腰交感神经链。④与“bl23”和卵巢相关的双标记(AF488-CTB和FG)感觉神经元主要分布在T12-T13 DRGs,节后交感神经元主要分布在腰交感神经链;与“cv4”和卵巢相关的双标记感觉神经元主要分布在T13-L1 DRGs,双标记节后交感神经元主要分布在腰交感神经链。卵巢各穴位均未见双标记运动神经元。结论“bl23”和“cv4”与大鼠卵巢在感觉和交感神经支配上存在节段性联系,这可能是针刺这些穴位调节卵巢功能的神经解剖学通路和依据。
{"title":"Neural anatomical connections between \"Shenshu(BL 23)\" \"Guanyuan(CV 4)\" and the ovary in rats","authors":"Huan-fang XU (许焕芳) ,&nbsp;Peng-fei DU (杜鹏飞) ,&nbsp;Dong-sheng XU (徐东升),&nbsp;Jing-jing Cui (崔晶晶),&nbsp;Yi-gong FANG (房繄恭),&nbsp;Jia WANG (王佳),&nbsp;Li YANG (杨莉)","doi":"10.1016/j.wjam.2025.09.008","DOIUrl":"10.1016/j.wjam.2025.09.008","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the distribution characteristics of sensory, sympathetic, and motor neurons associated with the \"Shenshu (BL 23)\" and \"Guanyuan (CV 4)\" acupoints and the ovary, and to elucidate the neural anatomical connections between these acupoints and the ovary.</div></div><div><h3>Methods</h3><div>In this study, dual fluorescent neural tracing was utilized, with twelve female Sprague-Dawley rats being randomly allocated into two groups (<em>n</em> = 6 per group) for the purpose of administering tracer injections at distinct anatomical sites: the \"BL 23\"-ovary group received injections of Alexa Fluor 488-conjugated cholera toxin subunit B (AF488-CTB) at the left \"BL 23\" and Fluoro-Gold (FG) in the left ovary; the \"CV 4\"-ovary group received AF488-CTB at “CV 4” and FG in the left ovary. Three days post-injection, the distribution of AF488-CTB and FG-labeled neural components was observed in the dorsal root ganglia (DRGs), sympathetic chain, and spinal cord tissues.</div></div><div><h3>Results</h3><div>① Sensory neurons labeled with AF488-CTB associated with \"BL 23\" were primarily distributed in the thoracic (T) 10 to lumbar (L) 2 DRGs, concentrated in T12-T13; postganglionic sympathetic neurons were mainly located in the thoracolumbar sympathetic chain; motor neurons were predominantly found in the anterior horn of the T11-L1 spinal cord segments. ② Sensory neurons labeled with AF488-CTB associated with \"CV 4\" were primarily located in T10-L3 DRGs, concentrated in T13-L2 DRGs; postganglionic sympathetic neurons were mainly distributed in the lumbar sympathetic chain; motor neurons were primarily found in the anterior horn of T11-L2 spinal cord segments. ③ FG-labeled sensory neurons associated with the ovary were mainly distributed in the T9-L3 DRGs, concentrated in the T12-L2 DRGs; postganglionic sympathetic neurons were primarily located in the lumbar sympathetic chain. ④ Double-labeled (AF488-CTB and FG) sensory neurons associated with the \"BL 23\" and ovary were mainly distributed in the T12-T13 DRGs, with double-labeled postganglionic sympathetic neurons primarily in the lumbar sympathetic chain; double-labeled sensory neurons associated with the \"CV 4\" and ovary were mainly distributed in the T13-L1 DRGs, with double-labeled postganglionic sympathetic neurons primarily in the lumbar sympathetic chain. No double-labeled motor neurons were observed for either acupoint with the ovary.</div></div><div><h3>Conclusion</h3><div>\"BL 23\" and \"CV 4\" and the ovary in rats exhibit segmental connections in sensory and sympathetic innervation, which may serve as the neural anatomical pathway and basis for acupuncture at these acupoints to regulate ovarian function.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 341-348"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of warm needling in patients with persistent allergic rhinitis: A multicenter randomized controlled trial 温针治疗持续性变应性鼻炎的疗效:一项多中心随机对照试验
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.09.009
Wen-bin NIE (聂文彬) , Qi FAN (范琦) , Yi-xuan FENG (丰逸轩) , Yu-xiu SUN (孙玉秀) , Shi-xi HUANG (黄石玺) , Yong-ming YE (叶永铭) , Ming-juan HAN (韩明娟) , Wen-jing BAI (白文静) , Hong ZHAO (赵宏)

Objective

Although there is evidence to support the therapeutic effect of acupuncture on allergic rhinitis (AR), it is not clear whether acupuncture can achieve an efficacy comparable to that of pharmacological therapy. This multicenter, non-inferiority, single-blinded randomized controlled trial aimed to compare the differences in efficacy between warm needling (WN) therapy and loratadine (LO) in improving AR symptoms and quality of life.

Methods

A total of 98 patients with persistent AR (PAR) were randomly divided into two groups in a 1:1 ratio: treatment group receiving WN therapy at Dazhui (GV14) and normal acupuncture at other acupoints for 12 sessions in 4 weeks and control group receiving LO at a dosage of 10 mg/day for oral administration. The study duration was 28 weeks (4-week treatment period with a 24-week follow-up). The primary outcome was the mean change in the Total Nasal Symptom Score (TNSS) from baseline to week 28, and the secondary outcomes included the Total Non-Nasal Symptom Score (TNNSS) and the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score. Statistical analyses were conducted using SPSS22.0. Both intention-to-treat and treatment compliance analyses were performed to analyze all outcomes.

Results

After intervention, TNSS scores improved from baseline to week 28 by 5.18 (95 % confidence interval [CI]: 3.91, 6.45; P < 0.001) in the WN group and 4.59 (95 % CI 3.28, 5.89; P < 0.001) in the LO group, but the changes did not differ between the groups (P = 0.515). The margin by 95 % CI (−1.20, 2.38) was not reached, indicating non-inferiority. WN therapy resulted in clinical improvements in TNNSS, with a significant difference compared with LO treatment (f = 5.466, P = 0.021). WN therapy also resulted in clinical improvements in RQLQ scores, with a significant difference compared with LO (f = 9.222, P = 0.003).

Conclusions

WN therapy demonstrated comparable efficacy to oral LO in improving nasal symptoms of PAR. However, it showed superior effects in alleviating concomitant nasal symptoms and enhancing patients’ quality of life.
Clinical Trial Registration: ClinicalTrials.gov Identifier NCT02339714.
目的虽然有证据支持针灸治疗变应性鼻炎(AR)的疗效,但目前尚不清楚针灸是否能达到与药物治疗相当的疗效。这项多中心、非劣效性、单盲随机对照试验旨在比较温针(WN)疗法和氯雷他定(LO)在改善AR症状和生活质量方面的疗效差异。方法将98例持续性AR (PAR)患者按1:1的比例随机分为两组:治疗组在大足穴(GV14)加其他穴位正常针刺,疗程12次,共4周;对照组口服LO,剂量为10 mg/d。研究时间为28周(治疗期4周,随访24周)。主要结局是总鼻症状评分(TNSS)从基线到第28周的平均变化,次要结局包括总非鼻症状评分(TNNSS)和鼻结膜炎生活质量问卷(RQLQ)评分。采用SPSS22.0进行统计分析。对所有结果进行意向治疗和治疗依从性分析。结果干预后,从基线到第28周,WN组的TNSS评分提高了5.18分(95%可信区间[CI]: 3.91, 6.45; P < 0.001), LO组的TNSS评分提高了4.59分(95% CI: 3.28, 5.89; P < 0.001),但两组之间的变化没有差异(P = 0.515)。未达到95% CI(- 1.20, 2.38),表明非劣效性。WN治疗可改善TNNSS的临床情况,与LO治疗相比差异有统计学意义(f = 5.466, P = 0.021)。治疗组RQLQ评分也有临床改善,与对照组相比差异有统计学意义(f = 9.222, P = 0.003)。结论swn治疗在改善PAR鼻部症状方面的疗效与口服LO相当,但在缓解伴有鼻部症状和提高患者生活质量方面效果更佳。临床试验注册:ClinicalTrials.gov标识符NCT02339714。
{"title":"Efficacy of warm needling in patients with persistent allergic rhinitis: A multicenter randomized controlled trial","authors":"Wen-bin NIE (聂文彬) ,&nbsp;Qi FAN (范琦) ,&nbsp;Yi-xuan FENG (丰逸轩) ,&nbsp;Yu-xiu SUN (孙玉秀) ,&nbsp;Shi-xi HUANG (黄石玺) ,&nbsp;Yong-ming YE (叶永铭) ,&nbsp;Ming-juan HAN (韩明娟) ,&nbsp;Wen-jing BAI (白文静) ,&nbsp;Hong ZHAO (赵宏)","doi":"10.1016/j.wjam.2025.09.009","DOIUrl":"10.1016/j.wjam.2025.09.009","url":null,"abstract":"<div><h3>Objective</h3><div>Although there is evidence to support the therapeutic effect of acupuncture on allergic rhinitis (AR), it is not clear whether acupuncture can achieve an efficacy comparable to that of pharmacological therapy. This multicenter, non-inferiority, single-blinded randomized controlled trial aimed to compare the differences in efficacy between warm needling (WN) therapy and loratadine (LO) in improving AR symptoms and quality of life.</div></div><div><h3>Methods</h3><div>A total of 98 patients with persistent AR (PAR) were randomly divided into two groups in a 1:1 ratio: treatment group receiving WN therapy at Dazhui (GV14) and normal acupuncture at other acupoints for 12 sessions in 4 weeks and control group receiving LO at a dosage of 10 mg/day for oral administration. The study duration was 28 weeks (4-week treatment period with a 24-week follow-up). The primary outcome was the mean change in the Total Nasal Symptom Score (TNSS) from baseline to week 28, and the secondary outcomes included the Total Non-Nasal Symptom Score (TNNSS) and the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score. Statistical analyses were conducted using SPSS22.0. Both intention-to-treat and treatment compliance analyses were performed to analyze all outcomes.</div></div><div><h3>Results</h3><div>After intervention, TNSS scores improved from baseline to week 28 by 5.18 (95 % confidence interval [CI]: 3.91, 6.45; <em>P</em> &lt; 0.001) in the WN group and 4.59 (95 % CI 3.28, 5.89; <em>P</em> &lt; 0.001) in the LO group, but the changes did not differ between the groups (<em>P</em> = 0.515). The margin by 95 % CI (−1.20, 2.38) was not reached, indicating non-inferiority. WN therapy resulted in clinical improvements in TNNSS, with a significant difference compared with LO treatment (<em>f</em> = 5.466, <em>P</em> = 0.021). WN therapy also resulted in clinical improvements in RQLQ scores, with a significant difference compared with LO (<em>f</em> = 9.222, <em>P</em> = 0.003).</div></div><div><h3>Conclusions</h3><div>WN therapy demonstrated comparable efficacy to oral LO in improving nasal symptoms of PAR. However, it showed superior effects in alleviating concomitant nasal symptoms and enhancing patients’ quality of life.</div><div>Clinical Trial Registration: <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> Identifier NCT02339714.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 349-356"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence map of systematic reviews on acupuncture and moxibustion for prevention and management of cancer-related conditions 针灸预防和治疗癌症相关疾病的系统评价证据图
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.09.007
Xiao-yan LYU (吕笑颜) , Xin-ru YUAN (袁馨如) , Zi-yang FAN (樊紫阳) , Jia-ni MA (马佳妮) , Chang-qi LI (李昌奇) , Xin-yang LI (李昕洋) , Hui ZHANG (张慧) , Li-yuan FU (傅丽媛) , Bin-xu SUN (孙彬栩) , Dan LI (李丹) , Xiao-hua WEN (温小华) , Tian-yi ZHAO (赵天易) , Mei-dan ZHAO (赵美丹) , Yi-nan GONG (公一囡) , Bin WANG (王斌) , Ao-xiang CHEN (陈翱翔) , Yi GUO (郭义) , Shi-yan YAN (闫世艳) , Bo CHEN (陈波)

Objective

In this study, we evaluated the methodological quality of systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions, aiming to provide evidence-based support and establish levels of evidence for clinical application.

Method

A comprehensive search was conducted to identify systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions, covering databases including PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Chinese Biomedical Databases, China Science and Technology Journal Database, and Wanfang Data, from their inception to August 1, 2024. The methodological quality of the included systematic reviews was assessed by using AMSTAR 2, and bubble plots were employed to visualize the evidence.

Results

Overall, 137 systematic reviews were included, with China being the most prolific country, with 117 reviews. These reviews addressed 21 cancer-related conditions, with the three most frequently studied being cancer-related fatigue (25 reviews), nausea and vomiting (20 reviews), and cancer pain (19 reviews). The three most commonly used acupuncture modalities were manual acupuncture (81 reviews), electroacupuncture (55 reviews), and moxibustion (39 reviews). Quality assessment revealed that one systematic review was rated as ``high quality,” eight as ``low quality,” and 128 as ``critically low quality,” primarily due to the absence of protocol registration and lists of excluded studies.

Conclusion

Acupuncture and moxibustion have shown potential efficacy in alleviating cancer-related conditions and treatment-related adverse effects, and their clinical use has been widely reported. However, the overall methodological quality of the included systematic reviews was low, limiting the reliability and the strength of the evidence. Future high-quality studies are needed to improve the quality of evidence and support the standardized application and broader promotion of acupuncture and moxibustion clinical practice.
目的评价针灸预防和治疗癌症相关疾病系统评价的方法学质量,旨在为临床应用提供循证支持和建立证据水平。方法综合检索PubMed、Embase、Cochrane图书馆、Web of Science、中国国家知识基础设施、中国生物医学数据库、中国科技期刊数据库、万方数据等数据库自建库至2024年8月1日期间关于针灸预防和管理癌症相关疾病的系统综述。采用AMSTAR 2对纳入的系统评价的方法学质量进行评估,并采用气泡图将证据可视化。结果共纳入137篇系统综述,其中中国是最多的国家,有117篇综述。这些综述涉及21种癌症相关疾病,其中最常被研究的三种是癌症相关疲劳(25篇综述)、恶心和呕吐(20篇综述)和癌症疼痛(19篇综述)。三种最常用的针灸方式是手动针灸(81篇综述)、电针(55篇综述)和艾灸(39篇综述)。质量评估显示,1项系统评价被评为“高质量”,8项被评为“低质量”,128项被评为“严重低质量”,主要原因是缺乏方案注册和排除研究清单。结论针灸在缓解肿瘤相关疾病和治疗相关不良反应方面具有潜在疗效,其临床应用已被广泛报道。然而,纳入的系统评价的整体方法学质量较低,限制了证据的可靠性和强度。今后需要开展高质量的研究,以提高证据质量,支持针灸临床实践的规范化应用和更广泛的推广。
{"title":"Evidence map of systematic reviews on acupuncture and moxibustion for prevention and management of cancer-related conditions","authors":"Xiao-yan LYU (吕笑颜) ,&nbsp;Xin-ru YUAN (袁馨如) ,&nbsp;Zi-yang FAN (樊紫阳) ,&nbsp;Jia-ni MA (马佳妮) ,&nbsp;Chang-qi LI (李昌奇) ,&nbsp;Xin-yang LI (李昕洋) ,&nbsp;Hui ZHANG (张慧) ,&nbsp;Li-yuan FU (傅丽媛) ,&nbsp;Bin-xu SUN (孙彬栩) ,&nbsp;Dan LI (李丹) ,&nbsp;Xiao-hua WEN (温小华) ,&nbsp;Tian-yi ZHAO (赵天易) ,&nbsp;Mei-dan ZHAO (赵美丹) ,&nbsp;Yi-nan GONG (公一囡) ,&nbsp;Bin WANG (王斌) ,&nbsp;Ao-xiang CHEN (陈翱翔) ,&nbsp;Yi GUO (郭义) ,&nbsp;Shi-yan YAN (闫世艳) ,&nbsp;Bo CHEN (陈波)","doi":"10.1016/j.wjam.2025.09.007","DOIUrl":"10.1016/j.wjam.2025.09.007","url":null,"abstract":"<div><h3>Objective</h3><div>In this study, we evaluated the methodological quality of systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions, aiming to provide evidence-based support and establish levels of evidence for clinical application.</div></div><div><h3>Method</h3><div>A comprehensive search was conducted to identify systematic reviews on acupuncture and moxibustion for the prevention and management of cancer-related conditions, covering databases including PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Chinese Biomedical Databases, China Science and Technology Journal Database, and Wanfang Data, from their inception to August 1, 2024. The methodological quality of the included systematic reviews was assessed by using AMSTAR 2, and bubble plots were employed to visualize the evidence.</div></div><div><h3>Results</h3><div>Overall, 137 systematic reviews were included, with China being the most prolific country, with 117 reviews. These reviews addressed 21 cancer-related conditions, with the three most frequently studied being cancer-related fatigue (25 reviews), nausea and vomiting (20 reviews), and cancer pain (19 reviews). The three most commonly used acupuncture modalities were manual acupuncture (81 reviews), electroacupuncture (55 reviews), and moxibustion (39 reviews). Quality assessment revealed that one systematic review was rated as ``high quality,” eight as ``low quality,” and 128 as ``critically low quality,” primarily due to the absence of protocol registration and lists of excluded studies.</div></div><div><h3>Conclusion</h3><div>Acupuncture and moxibustion have shown potential efficacy in alleviating cancer-related conditions and treatment-related adverse effects, and their clinical use has been widely reported. However, the overall methodological quality of the included systematic reviews was low, limiting the reliability and the strength of the evidence. Future high-quality studies are needed to improve the quality of evidence and support the standardized application and broader promotion of acupuncture and moxibustion clinical practice.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 290-302"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanisms of tumor growth inhibition by electroacupuncture in breast cancer-bearing mice 电针抑制乳腺癌小鼠肿瘤生长的机制
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.07.001
Xue-chao HUANG (黄学超) , Jing-xuan LIU (刘敬萱) , Tian-yu LI (李天玉) , Rui ZHANG (张锐) , Qian MO (默倩) , Guo-wu LEI (雷国伍) , Ran-ran LIU (刘冉冉) , Chun-sheng JIA (贾春生) , Li-Jia PAN (潘丽佳)
<div><h3>Objective</h3><div>To explore the mechanism of electroacupuncture (EA) on inhibiting tumor growth in breast cancer-bearing mice.</div></div><div><h3>Methods</h3><div>Thirty Bagg Albino (c) (BALB/c) mice were randomly divided into a sham-operation group, a tumor group, a chemotherapy group, and an acupuncture group, and an EA group, with six mice in each one. Except in the sham-operation group, 4T1 cells were injected into the fourth mammary fat pad on the right side of each mouse in the rest groups to develop breast-cancer bearing models. In the sham-operation group, the sham operation was underwent by injecting normal saline with the same volume as 4T1 cell suspension. After successful modeling, the intraperitoneal injection of doxorubicin solution was delivered in the chemotherapy group. In the acupuncture group, needles was inserted at “Zusanli” (ST36) and “Sanyinjiao” (SP6) perpendicularly, without manipulation, once daily and needles were retained for 15 min. In the EA group, on the basis of the operation as the acupuncture group, electric stimulation was attached to “ST36” (positive electrode) and “SP6” (negative electrode), once daily, 15 min each time. Starting on Day 1 of intervention, the changes of tumor volume was observed once every two days in each group photographed. The sample was collected on Day 21 of intervention. The tumors were photographed and weighed. Hematoxylin-eosin (HE) staining was used to observe the pathological changes of tumor tissue. Western blot, fluorescence quantitative polymerase chain reaction (FQ-PCR), and immunohistochemistry (IHC) were adopted to detect the protein expression, mRNA expression, and positive expression of CYLD, BCL-3, and P50 in tumor tissue, respectively.</div></div><div><h3>Results</h3><div>(1) The tumor volume in the tumor group, chemotherapy group, acupuncture group, and EA group was (815.67 ± 275.61) mm<sup>3</sup>, (197.50 ± 66.11) mm<sup>3</sup>, (412.62 ± 58.96) mm³, and (327.51 ± 125.46) mm<sup>3</sup>, respectively, and the tumor mass was (1.21 ± 0.39) g, (0.39 ± 0.05) g, (0.66 ± 0.06) g, and (0.55 ± 0.11) g on Day 21 of intervention, respectively. Compared with the tumor group, the tumor volume and mass were lower in the chemotherapy group, acupuncture group, and EA group (<em>P</em> < 0.05). (2) Respectively, in the tumor group, chemotherapy group, acupuncture group, and EA group, the mRNA expression of CYLD in tumor tissue was 1.01 ± 0.19, 2.90 ± 0.24, 2.55 ± 0.03, and 4.01 ± 0.32; the protein expression was 1.00 ± 0.00, 1.88 ± 0.16, 1.64 ± 0.11, and 2.30 ± 0.29; and the positive expression was 0.06 ± 0.01, 0.11 ± 0.01, 0.11 ± 0.004, and 0.14 ± 0.003. Compared with the tumor group, the mRNA expression, protein expression, and positive expression of CYLD were higher in the intervention groups (<em>P</em> < 0.05), and each expression in the EA group was higher in comparison with the chemotherapy and acupuncture groups (<em>P</em> < 0.05). (3) The mRNA expression
目的探讨电针抑制乳腺癌小鼠肿瘤生长的作用机制。方法30只BALB/c小鼠随机分为假手术组、肿瘤组、化疗组、针刺组和EA组,每组6只。除假手术组外,其余各组均在每只小鼠右侧第四个乳腺脂肪垫注射4T1细胞,建立乳腺癌负重模型。假手术组采用与4T1细胞悬液等量的生理盐水进行假手术。造模成功后,化疗组腹腔注射阿霉素溶液。针刺组在足三里(ST36)、三阴交(SP6)处垂直扎针,无手法,每日1次,留针15 min。EA组在针刺组手术的基础上,对“ST36”(正极)和“SP6”(负极)进行电刺激,每日1次,每次15 min。从干预第1天开始,每2天拍照1次,观察各组肿瘤体积变化。在干预的第21天采集样本。对肿瘤拍照并称重。采用苏木精-伊红(HE)染色观察肿瘤组织的病理变化。采用Western blot、荧光定量聚合酶链反应(FQ-PCR)和免疫组化(IHC)分别检测肿瘤组织中CYLD、BCL-3、P50的蛋白表达、mRNA表达和阳性表达。结果(1)肿瘤组、化疗组、针刺组、EA组肿瘤体积分别为(815.67±275.61)mm3、(197.50±66.11)mm3、(412.62±58.96)mm³、(327.51±125.46)mm3,干预第21天肿瘤体积分别为(1.21±0.39)g、(0.39±0.05)g、(0.66±0.06)g、(0.55±0.11)g。与肿瘤组比较,化疗组、针刺组、电针组肿瘤体积、体积均小于肿瘤组(P < 0.05)。(2)肿瘤组、化疗组、针刺组、EA组肿瘤组织中CYLD mRNA表达量分别为1.01±0.19、2.90±0.24、2.55±0.03、4.01±0.32;蛋白表达量分别为1.00±0.00、1.88±0.16、1.64±0.11、2.30±0.29;阳性表达分别为0.06±0.01、0.11±0.01、0.11±0.004、0.14±0.003。干预组CYLD mRNA表达、蛋白表达、阳性表达均高于肿瘤组(P < 0.05), EA组CYLD各项表达均高于化疗组和针刺组(P < 0.05)。(3) BCL-3 mRNA在肿瘤组织中的表达量分别为3.34±0.27、1.11±0.04、1.25±0.10和1.00±0.04;蛋白表达量分别为1.00±0.00、0.59±0.15、0.38±0.08和0.38±0.13;肿瘤组、化疗组、针刺组、EA组的阳性表达分别为0.12±0.01、0.06±0.02、0.07±0.01、0.05±0.003。与肿瘤组比较,干预组的mRNA表达、蛋白表达、BCL-3阳性表达均低于肿瘤组(P < 0.05)。(4) P50在肿瘤组织中的mRNA表达量分别为3.69±0.17、1.69±0.07、1.74±0.05和1.00±0.06;蛋白表达量分别为1.00±0.00、0.33±0.15、0.67±0.14、0.38±0.21;肿瘤组、化疗组、针刺组、EA组的阳性表达量分别为0.13±0.01、0.07±0.02、0.08±0.003、0.06±0.01。与肿瘤组相比,干预组小鼠肿瘤组织中mRNA表达、蛋白表达和P50阳性表达均较低(P < 0.05), EA组mRNA表达低于化疗组和针刺组(P < 0.05),而化疗组P50蛋白表达低于针刺组(P < 0.05)。结论化疗、针刺、EA均能抑制肿瘤生长,其作用机制可能与上调乳腺癌组织CYLD表达、下调BCL-3、P50表达有关。与化疗和针刺相比,EA在上调CYLD表达方面具有明显的优势。
{"title":"Mechanisms of tumor growth inhibition by electroacupuncture in breast cancer-bearing mice","authors":"Xue-chao HUANG (黄学超) ,&nbsp;Jing-xuan LIU (刘敬萱) ,&nbsp;Tian-yu LI (李天玉) ,&nbsp;Rui ZHANG (张锐) ,&nbsp;Qian MO (默倩) ,&nbsp;Guo-wu LEI (雷国伍) ,&nbsp;Ran-ran LIU (刘冉冉) ,&nbsp;Chun-sheng JIA (贾春生) ,&nbsp;Li-Jia PAN (潘丽佳)","doi":"10.1016/j.wjam.2025.07.001","DOIUrl":"10.1016/j.wjam.2025.07.001","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To explore the mechanism of electroacupuncture (EA) on inhibiting tumor growth in breast cancer-bearing mice.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Thirty Bagg Albino (c) (BALB/c) mice were randomly divided into a sham-operation group, a tumor group, a chemotherapy group, and an acupuncture group, and an EA group, with six mice in each one. Except in the sham-operation group, 4T1 cells were injected into the fourth mammary fat pad on the right side of each mouse in the rest groups to develop breast-cancer bearing models. In the sham-operation group, the sham operation was underwent by injecting normal saline with the same volume as 4T1 cell suspension. After successful modeling, the intraperitoneal injection of doxorubicin solution was delivered in the chemotherapy group. In the acupuncture group, needles was inserted at “Zusanli” (ST36) and “Sanyinjiao” (SP6) perpendicularly, without manipulation, once daily and needles were retained for 15 min. In the EA group, on the basis of the operation as the acupuncture group, electric stimulation was attached to “ST36” (positive electrode) and “SP6” (negative electrode), once daily, 15 min each time. Starting on Day 1 of intervention, the changes of tumor volume was observed once every two days in each group photographed. The sample was collected on Day 21 of intervention. The tumors were photographed and weighed. Hematoxylin-eosin (HE) staining was used to observe the pathological changes of tumor tissue. Western blot, fluorescence quantitative polymerase chain reaction (FQ-PCR), and immunohistochemistry (IHC) were adopted to detect the protein expression, mRNA expression, and positive expression of CYLD, BCL-3, and P50 in tumor tissue, respectively.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;(1) The tumor volume in the tumor group, chemotherapy group, acupuncture group, and EA group was (815.67 ± 275.61) mm&lt;sup&gt;3&lt;/sup&gt;, (197.50 ± 66.11) mm&lt;sup&gt;3&lt;/sup&gt;, (412.62 ± 58.96) mm³, and (327.51 ± 125.46) mm&lt;sup&gt;3&lt;/sup&gt;, respectively, and the tumor mass was (1.21 ± 0.39) g, (0.39 ± 0.05) g, (0.66 ± 0.06) g, and (0.55 ± 0.11) g on Day 21 of intervention, respectively. Compared with the tumor group, the tumor volume and mass were lower in the chemotherapy group, acupuncture group, and EA group (&lt;em&gt;P&lt;/em&gt; &lt; 0.05). (2) Respectively, in the tumor group, chemotherapy group, acupuncture group, and EA group, the mRNA expression of CYLD in tumor tissue was 1.01 ± 0.19, 2.90 ± 0.24, 2.55 ± 0.03, and 4.01 ± 0.32; the protein expression was 1.00 ± 0.00, 1.88 ± 0.16, 1.64 ± 0.11, and 2.30 ± 0.29; and the positive expression was 0.06 ± 0.01, 0.11 ± 0.01, 0.11 ± 0.004, and 0.14 ± 0.003. Compared with the tumor group, the mRNA expression, protein expression, and positive expression of CYLD were higher in the intervention groups (&lt;em&gt;P&lt;/em&gt; &lt; 0.05), and each expression in the EA group was higher in comparison with the chemotherapy and acupuncture groups (&lt;em&gt;P&lt;/em&gt; &lt; 0.05). (3) The mRNA expression ","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 367-375"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145499884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupuncture for the treatment of temporomandibular disorders: A systematic review and meta-analysis 针灸治疗颞下颌紊乱:系统回顾和荟萃分析
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.09.002
Quan MIAO (苗荃), Qiu-yi CHEN (陈秋怡), Sheng-xian LI (李晟贤), Wo-yu WANG (王握瑜), Li-min NIE (聂利敏), Shu-ting LI (郦淑婷), Ying LIN (林颖), Yu-han LIU (刘昱含), Lu LIU (刘璐), Bin LI (李彬)

Background

Temporomandibular disorders (TMD) are the leading cause of chronic orofacial pain, which significantly affects patients’ quality of life. However, the efficacy of acupuncture in the management of TMD remains unclear.

Objective

This systematic review aimed to conduct a PRISMA-compliant review to critically assess the therapeutic efficacy of acupuncture as an intervention for patients with TMD.

Methods

We searched nine electronic databases for randomized controlled trials on acupuncture for TMD published up to February 4, 2025. Eligible studies included adults diagnosed with TMD and compared acupuncture (manual, electroacupuncture, warm, auricular, thread-embedding, or laser) with conservative treatment (positive control) or sham acupuncture (negative control). Outcomes included pain intensity, mouth opening, pressure pain threshold, and adverse events. Risk of bias was assessed using ROB 2, and certainty of evidence was evaluated using GRADE. All outcome data were analyzed using RevMan 5.4 software. Low heterogeneity was defined as I² ≤ 50% and P ≥ 0.1, in which case a fixed-effects model was applied. High heterogeneity (I² > 50% or P < 0.1) prompted further analysis to identify its source. After excluding the influence of evident heterogeneity, a random-effects model was used for the meta-analysis.

Results

Of the 2664 screened records, 14 randomized controlled trials involving 476 participants met the inclusion criteria. Acupuncture significantly reduced pain intensity compared with that of negative controls (MD = −1.75, 95% confidence interval [CI] −2.47 to −1.03; P < 0.00001; I² = 60%) but showed no difference compared with that of positive controls (MD = −0.06, 95% CI −0.62 to 0.50; P = 0.83; I² = 0%). No significant differences were observed in pain-free jaw opening, whereas acupuncture improved maximum mouth opening relative to negative controls (MD = 1.80, 95% CI 1.62 to 1.97; P < 0.00001; I² = 0%). For pressure pain threshold, two small studies suggested greater increases with acupuncture. Safety data were limited, with only one trial reporting mild adverse events in the acupuncture group.

Conclusion

Based on limited evidence, acupuncture appears superior to negative controls in relieving pain associated with TMD but shows no significant advantage over positive controls. The certainty of the evidence for all outcomes, as assessed by GRADE, was low or very low. Therefore, these findings should be interpreted with caution. Future high-quality randomized controlled trials are warranted to further evaluate the role of acupuncture in the management of patients with TMD.
背景颞下颌紊乱(temporomandibular disorders, TMD)是导致慢性口面部疼痛的主要原因,严重影响患者的生活质量。然而,针灸治疗TMD的疗效尚不清楚。目的:本系统综述旨在进行一项符合prisma的综述,以批判性地评估针灸作为TMD患者干预的治疗效果。方法检索截至2025年2月4日发表的9个电子数据库中针灸治疗TMD的随机对照试验。符合条件的研究包括诊断为TMD的成年人,并将针灸(手工、电针、温针、耳针、埋线或激光)与保守治疗(阳性对照)或假针灸(阴性对照)进行比较。结果包括疼痛强度、开口、压痛阈和不良事件。使用ROB 2评估偏倚风险,使用GRADE评估证据的确定性。所有结局数据采用RevMan 5.4软件进行分析。低异质性定义为I²≤50%且P≥0.1,此时采用固定效应模型。高异质性(I²>; 50%或P <; 0.1)促使进一步分析以确定其来源。排除明显异质性的影响后,采用随机效应模型进行meta分析。结果在2664项筛选记录中,14项随机对照试验(476名受试者)符合纳入标准。与阴性对照组相比,针刺可显著降低疼痛强度(MD = - 1.75, 95%可信区间[CI] - 2.47 ~ - 1.03; P < 0.00001; I²= 60%),但与阳性对照组相比无差异(MD = - 0.06, 95% CI - 0.62 ~ 0.50; P = 0.83; I²= 0%)。与阴性对照组相比,无痛颌开口无显著差异,而针灸改善了最大开口(MD = 1.80, 95% CI 1.62至1.97;P < 0.00001; I²= 0%)。对于压痛阈值,两项小型研究表明针灸会增加更多。安全性数据有限,只有一项试验报告了针灸组的轻度不良事件。结论基于有限的证据,针灸在缓解TMD相关疼痛方面优于阴性对照,但与阳性对照相比没有明显优势。根据GRADE评估,所有结局的证据的确定性都很低或很低。因此,这些发现应谨慎解释。未来有必要进行高质量的随机对照试验,以进一步评估针灸在TMD患者治疗中的作用。
{"title":"Acupuncture for the treatment of temporomandibular disorders: A systematic review and meta-analysis","authors":"Quan MIAO (苗荃),&nbsp;Qiu-yi CHEN (陈秋怡),&nbsp;Sheng-xian LI (李晟贤),&nbsp;Wo-yu WANG (王握瑜),&nbsp;Li-min NIE (聂利敏),&nbsp;Shu-ting LI (郦淑婷),&nbsp;Ying LIN (林颖),&nbsp;Yu-han LIU (刘昱含),&nbsp;Lu LIU (刘璐),&nbsp;Bin LI (李彬)","doi":"10.1016/j.wjam.2025.09.002","DOIUrl":"10.1016/j.wjam.2025.09.002","url":null,"abstract":"<div><h3>Background</h3><div>Temporomandibular disorders (TMD) are the leading cause of chronic orofacial pain, which significantly affects patients’ quality of life. However, the efficacy of acupuncture in the management of TMD remains unclear.</div></div><div><h3>Objective</h3><div>This systematic review aimed to conduct a PRISMA-compliant review to critically assess the therapeutic efficacy of acupuncture as an intervention for patients with TMD.</div></div><div><h3>Methods</h3><div>We searched nine electronic databases for randomized controlled trials on acupuncture for TMD published up to February 4, 2025. Eligible studies included adults diagnosed with TMD and compared acupuncture (manual, electroacupuncture, warm, auricular, thread-embedding, or laser) with conservative treatment (positive control) or sham acupuncture (negative control). Outcomes included pain intensity, mouth opening, pressure pain threshold, and adverse events. Risk of bias was assessed using ROB 2, and certainty of evidence was evaluated using GRADE. All outcome data were analyzed using RevMan 5.4 software. Low heterogeneity was defined as <em>I</em>² ≤ 50% and <em>P</em> ≥ 0.1, in which case a fixed-effects model was applied. High heterogeneity (<em>I</em>² &gt; 50% or <em>P</em> &lt; 0.1) prompted further analysis to identify its source. After excluding the influence of evident heterogeneity, a random-effects model was used for the meta-analysis.</div></div><div><h3>Results</h3><div>Of the 2664 screened records, 14 randomized controlled trials involving 476 participants met the inclusion criteria. Acupuncture significantly reduced pain intensity compared with that of negative controls (MD = −1.75, 95% confidence interval [CI] −2.47 to −1.03; <em>P</em> &lt; 0.00001; I² = 60%) but showed no difference compared with that of positive controls (MD = −0.06, 95% CI −0.62 to 0.50; <em>P</em> = 0.83; I² = 0%). No significant differences were observed in pain-free jaw opening, whereas acupuncture improved maximum mouth opening relative to negative controls (MD = 1.80, 95% CI 1.62 to 1.97; <em>P</em> &lt; 0.00001; I² = 0%). For pressure pain threshold, two small studies suggested greater increases with acupuncture. Safety data were limited, with only one trial reporting mild adverse events in the acupuncture group.</div></div><div><h3>Conclusion</h3><div>Based on limited evidence, acupuncture appears superior to negative controls in relieving pain associated with TMD but shows no significant advantage over positive controls. The certainty of the evidence for all outcomes, as assessed by GRADE, was low or very low. Therefore, these findings should be interpreted with caution. Future high-quality randomized controlled trials are warranted to further evaluate the role of acupuncture in the management of patients with TMD.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 320-330"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupuncture treatment for Bartholin’s abscesst: A case report and literature review 针刺治疗巴托林脓肿1例并文献复习
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.09.005
Xiao-xuan GENG (耿晓萱), Sheng CHEN (陈晟), Wen-yi YANG (杨文夷), Mei-lun HUANG (黄美伦), Jia-le KANG (康家乐)
A 30-year-old female patient with Bartholin’s abscess was treated by acupuncture. Before visit, she had taken wuwei xiaodu yin for 4 consecutive days, but the symptoms were not alleviated markedly and pain was worsening. According to the conditions of tongue and pulse, and physical signs, the case was differentiated as pathogenic heat invading blood phase; and the injury of qi and yin by the herbal decoction the patient took before. In treatment with acupuncture, the treatment principle focused on benefiting qi, nourishing yin, expelling pus from the interior and draining toxin, and promoting the circulations of meridians to stop pain. He-sea points were selected to clear heat and resolve damp, and replenish the liver and kidney; and the acupoints of bladder meridian were combined under the guidance of “taiyang dominating the openings,” aiming at elevating qi and expelling toxin from the interior. Acupuncture was given once daily. After treated for 4 days, abscess was ruptured, pain disappeared, and no recurrence was presented and no sequelae happened during over 2 years of follow-up. This case shows that acupuncture is effective on Bartholin’s abscess. By reviewing this case, it is put forward that there may by the signs before the onset of Bartholin’s abscess, and the treatment should focus on opening a way for eliminating pathogens. Moreover, the clinical trial is required to verify acupuncture effect on this disease.
本文对30岁女性患者巴托林脓肿进行针灸治疗。就诊前,患者连续服用无味消毒饮4天,症状未明显缓解,疼痛加重。根据舌脉情况及体征,将本病定性为热侵血相;患者服用的中药汤剂对气阴损伤的影响。在针灸治疗中,治疗原则侧重于益气,滋阴,排出脓液,排出毒素,促进经络循环,以止痛。选用合海穴清热化湿,补肝肾;膀胱经的腧穴在“阳占开”的指导下结合,旨在从内部提气排毒。每天针灸一次。治疗4天后,脓肿破裂,疼痛消失,随访2年多无复发,无后遗症。本病例表明针灸治疗巴托林脓肿有效。通过对本病例的回顾,提出巴托林脓肿在发病前可能存在体征,治疗应注重开辟病原体清除途径。此外,还需要临床试验来验证针灸对本病的疗效。
{"title":"Acupuncture treatment for Bartholin’s abscesst: A case report and literature review","authors":"Xiao-xuan GENG (耿晓萱),&nbsp;Sheng CHEN (陈晟),&nbsp;Wen-yi YANG (杨文夷),&nbsp;Mei-lun HUANG (黄美伦),&nbsp;Jia-le KANG (康家乐)","doi":"10.1016/j.wjam.2025.09.005","DOIUrl":"10.1016/j.wjam.2025.09.005","url":null,"abstract":"<div><div>A 30-year-old female patient with Bartholin’s abscess was treated by acupuncture. Before visit, she had taken <em>wuwei xiaodu yin</em> for 4 consecutive days, but the symptoms were not alleviated markedly and pain was worsening. According to the conditions of tongue and pulse, and physical signs, the case was differentiated as pathogenic heat invading blood phase; and the injury of <em>qi</em> and <em>yin</em> by the herbal decoction the patient took before. In treatment with acupuncture, the treatment principle focused on benefiting <em>qi</em>, nourishing <em>yin</em>, expelling pus from the interior and draining toxin, and promoting the circulations of meridians to stop pain. <em>He</em>-sea points were selected to clear heat and resolve damp, and replenish the liver and kidney; and the acupoints of bladder meridian were combined under the guidance of “<em>taiyang</em> dominating the openings,” aiming at elevating <em>qi</em> and expelling toxin from the interior. Acupuncture was given once daily. After treated for 4 days, abscess was ruptured, pain disappeared, and no recurrence was presented and no sequelae happened during over 2 years of follow-up. This case shows that acupuncture is effective on Bartholin’s abscess. By reviewing this case, it is put forward that there may by the signs before the onset of Bartholin’s abscess, and the treatment should focus on opening a way for eliminating pathogens. Moreover, the clinical trial is required to verify acupuncture effect on this disease.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 384-387"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adrenergic agonist therapy and emerging acupuncture targets in asthma: A review of mechanisms and therapeutic implications 肾上腺素能激动剂治疗和新出现的针灸靶点在哮喘:机制和治疗意义的回顾
IF 1.3 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-10-01 DOI: 10.1016/j.wjam.2025.08.002
Jin LU (卢进) , Jun-tao FENG (冯俊涛) , Lei-miao YIN (尹磊淼) , Yong-qing YANG (杨永清)
The development of adrenergic agonists (AAs) for asthma has provided important mechanistic insights into acupuncture-based target discovery and treatment strategies. This review describes the historical evolution of AA therapy, including the precise optimization of nonselective to β₂-selective agonists, improvement from short-acting to ultra-long-acting agents, shift from targeted monotherapy to combination regimens, and alterations in drug formulation. Additionally, this review summarizes recent advances in acupuncture treatment for asthma, including the development of novel targeted therapies, application of acupuncture-based combination regimens, and optimization of the mode of administration. Taken together, this article discusses key insights from research on AA that inform acupuncture approaches, with a focus on: (1) precision targeting: identifying acupuncture-specific targets to improve efficacy; (2) synergistic treatment: employing multi-target combination regimens to enhance therapeutic outcomes; (3) formulation innovation: advancing acupuncture delivery methods to improve patient compliance; and (4) evidence-based development: strengthening clinical research to generate high-quality evidence to inform the discovery of novel targets and treatment strategies for asthma.
肾上腺素能激动剂(AAs)治疗哮喘的发展为基于针灸的靶点发现和治疗策略提供了重要的机制见解。本文综述了AA治疗的历史演变,包括非选择性激动剂到β 2选择性激动剂的精确优化,从短效药物到超长效药物的改进,从靶向单一治疗到联合治疗方案的转变,以及药物配方的改变。此外,本文还综述了针刺治疗哮喘的最新进展,包括新型靶向治疗的发展、针灸联合治疗方案的应用以及给药方式的优化。综上所述,本文讨论了AA研究对针灸方法的重要启示,重点是:(1)精确靶向:确定针灸特异性靶点以提高疗效;(2)协同治疗:采用多靶点联合治疗方案,提高治疗效果;(3)配方创新:推进针灸给药方式,提高患者依从性;(4)循证发展:加强临床研究,产生高质量的证据,为发现哮喘的新靶点和治疗策略提供信息。
{"title":"Adrenergic agonist therapy and emerging acupuncture targets in asthma: A review of mechanisms and therapeutic implications","authors":"Jin LU (卢进) ,&nbsp;Jun-tao FENG (冯俊涛) ,&nbsp;Lei-miao YIN (尹磊淼) ,&nbsp;Yong-qing YANG (杨永清)","doi":"10.1016/j.wjam.2025.08.002","DOIUrl":"10.1016/j.wjam.2025.08.002","url":null,"abstract":"<div><div>The development of adrenergic agonists (AAs) for asthma has provided important mechanistic insights into acupuncture-based target discovery and treatment strategies. This review describes the historical evolution of AA therapy, including the precise optimization of nonselective to β₂-selective agonists, improvement from short-acting to ultra-long-acting agents, shift from targeted monotherapy to combination regimens, and alterations in drug formulation. Additionally, this review summarizes recent advances in acupuncture treatment for asthma, including the development of novel targeted therapies, application of acupuncture-based combination regimens, and optimization of the mode of administration. Taken together, this article discusses key insights from research on AA that inform acupuncture approaches, with a focus on: (1) precision targeting: identifying acupuncture-specific targets to improve efficacy; (2) synergistic treatment: employing multi-target combination regimens to enhance therapeutic outcomes; (3) formulation innovation: advancing acupuncture delivery methods to improve patient compliance; and (4) evidence-based development: strengthening clinical research to generate high-quality evidence to inform the discovery of novel targets and treatment strategies for asthma.</div></div>","PeriodicalId":44648,"journal":{"name":"World Journal of Acupuncture-Moxibustion","volume":"35 4","pages":"Pages 269-275"},"PeriodicalIF":1.3,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145500438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World Journal of Acupuncture-Moxibustion
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1